These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17704752)

  • 1. Radio-responsive TRAIL gene therapy for malignant gliomas.
    Kyritsis AP; Rao JS; Puduvalli VK
    Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.
    Tsurushima H; Yuan X; Dillehay LE; Leong KW
    Cancer Gene Ther; 2007 Aug; 14(8):706-16. PubMed ID: 17541421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
    Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
    Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-inducible caspase-8 gene therapy for malignant brain tumors.
    Tsurushima H; Yuan X; Dillehay LE; Leong KW
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):517-25. PubMed ID: 18407431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.
    Lu W; Sun Q; Wan J; She Z; Jiang XG
    Cancer Res; 2006 Dec; 66(24):11878-87. PubMed ID: 17178885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
    Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
    Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
    Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
    Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy for brain tumors: induction of apoptosis and immunogenic modulation in glioma cells (series 5)].
    Asai A
    No Shinkei Geka; 1995 Jan; 23(1):7-15. PubMed ID: 7845524
    [No Abstract]   [Full Text] [Related]  

  • 12. 2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
    Mukai S; Kondo Y; Koga S; Komata T; Barna BP; Kondo S
    Cancer Res; 2000 Aug; 60(16):4461-7. PubMed ID: 10969793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of malignant brain tumors by using apoptosis].
    Kuchino Y
    No To Shinkei; 1995 Sep; 47(9):829-34. PubMed ID: 7546931
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas.
    Uzzaman M; Keller G; Germano IM
    Neuro Oncol; 2009 Apr; 11(2):102-8. PubMed ID: 18676359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
    Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat.
    Liang B; He ML; Chan CY; Chen YC; Li XP; Li Y; Zheng D; Lin MC; Kung HF; Shuai XT; Peng Y
    Biomaterials; 2009 Aug; 30(23-24):4014-20. PubMed ID: 19427690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New innovations and developments for glioma treatment.
    Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M
    Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biology and gene therapy of glioma].
    Sanson M; Hoang-Xuan K
    Rev Prat; 1996 Feb; 46(4):464-8. PubMed ID: 8729353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts.
    Liu Y; Lang F; Xie X; Prabhu S; Xu J; Sampath D; Aldape K; Fuller G; Puduvalli VK
    Cell Death Dis; 2011 Feb; 2(2):e121. PubMed ID: 21368892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.